Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma

CD19-targeted CAR T cell immunotherapy has exceptional efficacy for the treatment of B-cell malignancies. B-cell acute lymphocytic leukemia and non-Hodgkin’s lymphoma are two common B-cell malignancies with high recurrence rate and are refractory to cure. Although CAR T-cell immunotherapy overcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jiwei, Huang, FeiMing, Chen, Lei, Feng, KaiYan, Jian, Fangfang, Huang, Tao, Cai, Yu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402909/
https://www.ncbi.nlm.nih.gov/pubmed/36033519
http://dx.doi.org/10.3389/fonc.2022.976262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402909/
https://www.ncbi.nlm.nih.gov/pubmed/36033519
http://dx.doi.org/10.3389/fonc.2022.976262

Ejemplares similares